We have previously shown that both Sig1R gene (S1R) and protein (Sig1R) expression positively correlate with poor patient survival and that TNBC samples express high levels of S1R compared to other breast cancer (BCa) subtypes [19]. This evidence concerns the gene SIGMAR1 and breast cancer.